IP Library › Assignment 063237/0439
Patent Assignment
Reel/Frame 063237/0439

Change of Owner/Applicant's Address

Recorded: 2023-04-03 Pages: 4
Assignor
Assignee
LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
TOUR W, 102 TERRASSE BOIELDIEU 19EME ETAGE, PUTEAUX, 92800, FRANCE
Covered Properties (58)
Anti-Fibrinogen Aptamers
Application: 17/389,878 →
Publication: US 2022/0098590
Factor VII Composition Having a Substantially Homogeneous Isoelectric Point
Application: 16/868,850 →
Publication: US 2020/0362329
Oral Composition of Anti-Tnf Alpha Antibodies
Application: 16/697,519 →
Publication: US 2020/0331994
Fc Mutants with Modified Functional Activity
Application: 15/554,022 →
Publication: US 2018/0030111
Method for the Cryopreservation of Cells for Therapeutic Purposes
Application: 15/737,469 →
Publication: US 2019/0000070
Use of Modified Fc Fragments in Immunotherapy
Application: 15/742,268 →
Publication: US 2018/0355034
Fc Mutants with Improved Functional Activity
Application: 16/315,356 →
Publication: US 2019/0309085
Stable Liquid Fibrinogen
Application: 16/315,388 →
Publication: US 2019/0209659
Fc Polypeptide Variants Having an Increased Half-Life
Application: 16/345,620 →
Publication: US 2019/0292269
Method for the Cryopreservation of Cells for Therapeutic Purposes
Application: 16/766,900 →
Publication: US 2021/0244016
Variants with Fc Fragment Having an Increased Affinity for Fcrn and an Increased Affinity for at Least One Receptor of the Fc Fragment
Application: 16/772,244 →
Publication: US 2021/0214434
Composition of Concentrated Human Immunoglobulins
Application: 17/056,626 →
Publication: US 2021/0205452
Combination of Factor Vii and an Anti-Factor Ix/X Bispecific Antibody
Application: 17/251,695 →
Publication: US 2022/0152197
Method of Preserving Cells for Therapeutic Use
Application: 17/293,867 →
Publication: US 2022/0226383
Sampling Device for Sampling from a Surface of an Industrial Vessel Without Requiring a Person to Descend into an Industrial Vessel, Using a Swab
Application: 17/297,504 →
Publication: US 2022/0034758
Method for Filtering Fibrinogen
Application: 17/416,143 →
Publication: US 2022/0056107
Glycols as Pathogen Inactivating Agents
Application: 16/162,735 →
Publication: US 2019/0254276
Glycols as Pathogen Inactivating Agents
Application: 13/994,207 →
Publication: US 2013/0324619
Cetuximab with Modified Glycosylation and Uses Thereof
Application: 14/767,089 →
Publication: US 2016/0002330
Optimized Fc Variants
Patent: 8,742,074 →
Application: 13/257,502 →
Publication: US 2012/0009188
Optimized Fc Variants
Patent: 45,992 →
Application: 14/338,413 →
Optimized Fc Variants
Patent: 46,585 →
Application: 14/993,277 →
Method for Purifying Transgenic Factor Vii/Viia
Patent: 9,982,247 →
Application: 14/415,254 →
Publication: US 2015/0175983
Use of Mutagenic Dna Polymerase for Producing Random Mutations
Patent: 7,670,809 →
Application: 10/416,424 →
Publication: US 2004/0110294
Method for Stabilising an Immunoglobulin G Composition in Liquid Form
Patent: 9,463,241 →
Application: 13/752,189 →
Publication: US 2013/0202585
Stabilising Formulation for Immunoglobulin G Compositions in Liquid Form and in Lyophilised Form
Patent: 8,388,954 →
Application: 10/552,314 →
Publication: US 2007/0036779
Method for Stabilizing a Cryoprecipitate of Plasmatic Proteins for Being Subjected to a Viral Inactivation Thermal Treatment
Patent: 7,727,743 →
Application: 10/563,620 →
Publication: US 2006/0247426
Use of ADCC-Optimized antibodies for treating weak patients
Patent: 8,501,171 →
Application: 12/659,824 →
Publication: US 2010/0303826
Use of Adcc-Optimized Antibodies for Treating Weak Patients
Patent: 9,109,020 →
Application: 13/930,070 →
Publication: US 2014/0017243
Use of Adcc-Optimized Antibodies for Treating Low-Responder Patients
Patent: 9,879,089 →
Application: 14/702,143 →
Publication: US 2015/0307624
Use of Adcc-Optimized Antibodies for Treating Low-Responder Patients
Patent: 7,713,524 →
Application: 10/566,358 →
Publication: US 2006/0182741
Virally-Safe Factor Viii with a Low Content of Higher Multimers
Patent: 7,932,355 →
Application: 10/576,794 →
Publication: US 2007/0275880
Albumin-Purification Method Comprising a Nanofiltration Step, Solution, and Composition for Therapeutic Use Containing the Same
Patent: 9,611,311 →
Application: 14/611,460 →
Publication: US 2015/0152162
Albumin-Purification Method Comprising a Nanofiltration Step, Solution, and Composition for Therapeutic Use Containing the Same
Application: 15/443,884 →
Publication: US 2017/0166626
An Antibody Method for Treatment of a Disease in Which the Target Cells Are Cells Which Express CD20
Patent: 9,873,745 →
Application: 14/828,177 →
Publication: US 2016/0060350
A Monoclonal Antibody Directed Against CD20 Antigen
Patent: 9,234,045 →
Application: 11/793,138 →
Publication: US 2009/0053233
Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
Patent: 8,598,319 →
Application: 11/477,212 →
Publication: US 2008/0207878
Process for Separating Proteins Fibrinogen, Factor Xiii and Biological Glue from a Solubilized Plasma Fraction and for Preparing Lyophilised Concentrates of Said Proteins
Patent: 9,339,530 →
Application: 14/056,886 →
Publication: US 2014/0148580
Process for Separating Proteins Fibrinogen, Factor Xiii and Biological Glue from a Solubilized Plasma Fraction and for Preparing Lyophilised Concentrates of Said Proteins
Patent: 9,320,779 →
Application: 14/056,903 →
Publication: US 2014/0154231
The Invention Relates to a Method of Viral Inactivation by Dry Heating
Patent: 8,252,227 →
Application: 12/097,860 →
Publication: US 2009/0297398
Immunoglobulin G (Igg) Concentrate Depleted of Anti-a and Anti-B Antibodies and of Polyreactive Iggs
Patent: 8,153,382 →
Application: 12/159,199 →
Publication: US 2009/0074749
Recombinant or Transgenic Factor Vii Composition, Each Factor Vii Molecule Having Two N-Glycosylation Sites with Defined Glycan Units
Application: 13/886,033 →
Publication: US 2014/0093491
Recombinant or Transgenic Factor Vii Composition, Each Factor Vii Molecule Having Two N-Glycosylation Sites with Defined Glycan Units
Application: 12/300,486 →
Publication: US 2009/0311239
Factor Vii Composition
Patent: 9,358,275 →
Application: 14/687,499 →
Publication: US 2015/0216951
Factor Vii Composition
Patent: 9,968,662 →
Application: 15/165,786 →
Publication: US 2016/0271233
Factor Vii Composition
Patent: 9,029,316 →
Application: 13/377,680 →
Publication: US 2012/0087908
Method for Treating Blood Plasma Including a Step of Washing by Means of Dispersion
Patent: 9,504,714 →
Application: 13/510,553 →
Publication: US 2013/0140237
Novel Signal Peptide, and Use Thereof for Producing Recombinant Proteins
Patent: 8,883,450 →
Application: 13/583,337 →
Publication: US 2013/0122546
Method for Measuring Igg-Mediated Complement Activation
Patent: 8,790,881 →
Application: 13/695,820 →
Publication: US 2013/0052659
Determination of the Thrombogenic Power of Human Immunoglobulins
Patent: 9,891,238 →
Application: 14/343,642 →
Publication: US 2014/0295471
Method for Preparing a Concentrate of Factor Xi
Patent: 9,181,323 →
Application: 14/112,175 →
Publication: US 2014/0046028
Transcription Unit and Use Thereof in Expression Vectors
Patent: 9,551,009 →
Application: 14/354,331 →
Publication: US 2014/0242638
Transcription Units and the Use Thereof in Expression Vectors
Patent: 9,512,230 →
Application: 14/375,503 →
Publication: US 2015/0072368
Factor VII Composition Having a Substantially Homogenous Isoelectric Point
Application: 16/868,803 →
Publication: US 2020/0270596
Transgenic Factor Vii Having a Specific N-Glycosylation and Substantially Homogenous Isoelectric Point
Application: 14/896,763 →
Publication: US 2016/0152965
Affinity Chromatography Matrix
Application: 14/902,716 →
Publication: US 2016/0168229
Method for Purification of Monoclonal Antibodies
Application: 15/508,577 →
Publication: US 2017/0274299
Cell Line Overexpressing Human CD303 Antigen
Application: 15/563,046 →
Publication: US 2018/0066060
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 17, 2013
From: BEHRENS, CHRISTIAN; JORIEUX, SYLVIE; KHARRAT, ABDELHAKIM; BOUAYADI, KHALIL
To: LFB BIOTECHNOLOGIES
Reel/Frame 029650/0027 →
Assignment of Assignor's Interest Jul 16, 2013
From: LFB-BIOTECHNOLOGIES
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 030802/0820 →
Assignment of Assignor's Interest Jul 19, 2013
From: CHTOUROU, SAMI
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 030835/0488 →
Assignment of Assignor's Interest Aug 20, 2013
From: LFB-BIOTECHNOLOGIES
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 031047/0295 →
Assignment of Assignor's Interest Feb 22, 2017
From: MEADE, HARRY M.
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 041336/0230 →
Assignment of Assignor's Interest Oct 3, 2017
From: MONNET, CÉLINE; MONDON, PHILIPPE; FONTAYNE, ALEXANDRE; DE ROMEUF, CHRISTOPHE
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 043763/0543 →
Assignment of Assignor's Interest Jun 4, 2018
From: DE LARICHAUDY, JOFFREY
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 045982/0476 →
Assignment of Assignor's Interest Oct 5, 2018
From: MONDON, PHILIPPE; MONNET-MARS, CELINE; FONTAYNE, ALEXANDRE; DE ROMEUF, CHRISTOPHE
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 047199/0650 →
Assignment of Assignor's Interest Jan 17, 2019
From: MONNET, CELINE
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 048044/0965 →
Assignment of Assignor's Interest Feb 7, 2019
From: BATAILLE, DAMIEN; TELLIER, MICHEL
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 048285/0139 →
Assignment of Assignor's Interest Feb 13, 2019
From: CHTOUROU, SAMI
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 048315/0846 →
Confirmatory Assignment Feb 13, 2019
From: LFB BIOTECHNOLOGIES
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 048323/0844 →
Assignment of Assignor's Interest Apr 26, 2019
From: MONNET, CÉLINE
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 049010/0796 →
Assignment of Assignor's Interest Mar 9, 2020
From: CHTOUROU, ABDESSATAR SAMI
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 052048/0354 →
Assignment of Assignor's Interest Sep 23, 2020
From: MEADE, HARRY; MONNET, CÉLINE; MONDON, PHILIPPE
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 053860/0731 →
Assignment of Assignor's Interest Mar 11, 2021
From: DE LARICHAUDY, JOFFREY; CAZALON NEMORIN, SANDY
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 055564/0750 →
Assignment of Assignor's Interest May 3, 2021
From: JAUME, CECILE
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 056122/0103 →
Assignment of Assignor's Interest May 27, 2021
From: OLIVIER, CHRISTOPHE; DUPUIS, OLIVIER; DELTOUR, QUENTIN
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 056367/0874 →
Assignment of Assignor's Interest Jul 2, 2021
From: BATAILLE, DAMIEN; OLLIVIER, MONIQUE; TELLIER, MICHEL
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 056743/0674 →
Assignment of Assignor's Interest Nov 12, 2021
From: PLANTIER, JEAN-LUC
To: LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 058096/0753 →
Assignment of Assignor's Interest May 31, 2022
From: DE LARICHAUDY, JOFFREY; CAZALON NEMORIN, SANDY
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 060053/0583 →
Change of Owner/Applicant's Address Sep 21, 2022
From: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
To: LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Reel/Frame 061493/0885 →